secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTENSITY THERAPEUTICS, INC. (INTS)
CIK:        0001567264
Form:       8-K
Filed at:   2024-07-17T23:59:59+00:00
Accession:  0001567264-24-000035
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intensity Therapeutics stockholders approve ESPP and re-elect directors at annual meeting
--------------------------------------------------------------------------------

- 8,522,632 shares represented (~62.15% quorum) at July 17, 2024 annual meeting.
- Daniel Donovan and Thomas I.H. Dubin re-elected as Class I directors until 2027.
- Stockholders approved 2024 Employee Stock Purchase Plan (ESPP) with 6.6M for, 103k against.
- EisnerAmper LLP ratified as independent auditor for fiscal year ending December 31, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1567264/000156726424000035/0001567264-24-000035-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1567264/000156726424000035/intensity-20240717.htm
  HTML page:      https://secwatch.observer/filing/0001567264-24-000035

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer